Get started
Author

Jean-Baptiste Barbe-Richaud

Antibody-Drug Conjugates as Novel Therapeutic Agents for Non-Small Cell Lung Carcinoma with or without Alterations in Oncogenic Drivers
2024 · Laura Bender Somme, Christos Chouaid, et al. · BioDrugs · 11
Human chlorine gas exposition and its management – an umbrella review on human data
2022 · Aboubakari Nambiema, Gabrielle Coyo, et al. · Critical Reviews in Toxicology · 9
PDF
Real-world treatment sequences and overall survival in metastatic bladder cancer: The STATES-Bladder study
2026 · Fabien Moinard-Butot, Jean-Baptiste Barbe-Richaud, et al. · Urologic Oncology Seminars and Original Investigations · 2
Prediction of survival and outcomes with depth of response at 6 months in metastatic non-small-cell lung cancer patients treated with chemotherapy and immunotherapy combination: SPORE trial
2026 · F. Moinard-Butot, J.-B. Barbe-Richaud, et al. · ESMO Open · 2
PDF
From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma
2026 · Jean-Baptiste Barbe-Richaud, Hélène Cebula, et al. · Journal of Neuro-Oncology · 1
PDF
Prolonged complete metabolic response to chemotherapy combined with amivantamab with high grade cutaneous toxicity after osimertinib resistance in an uncommon T751_I759delinsAsp EGFR-mutant lung adenocarcinoma: a case report
2026 · Jean-Baptiste Barbe-Richaud, Erwan Pencreach, et al. · Translational Lung Cancer Research · 1
EGFR-Mutant Urothelial Carcinoma Harboring an Ala750_Ile759delinsGlyGly Alteration with a Primary Resistance to Polychemotherapy and a Sensitivity to Osimertinib: A Literature Review on EGFR Alterations and Response to EGFR Tyrosine Kinase Inhibitors in Cancers
2025 · Jean-Baptiste Barbe-Richaud, Antonin Fattori, et al. · Journal of Clinical Medicine · 1
PDF
Real world effectiveness of systemic treatment in patients (pts) with advanced upper tract urothelial carcinoma (UTUC) with histological variants.
2025 · Fabien Moinard-Butot, Karim Amrane, et al. · Journal of Clinical Oncology · 1
PDF
201P Retrospective multicenter real-life study evaluating the efficacy of atezolizumab in combination with bevacizumab in metastatic hepatocellular carcinoma: HIREAL study
2024 · F. Moinard-Butot, J-B. Barbe-Richaud, et al. · Annals of Oncology · 1
PDF
A retrospective evaluation of treatment patterns following cabozantinib treatment for advanced renal cancer: The CABONEXT study.
2026 · Simon Nannini, Fabien Moinard-Butot, et al. · Journal of Clinical Oncology
First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer
2025 · Simon Nannini, Fabien Moinard-Butot, et al.
PDF
Efficacy of Enfortumab-Vedotin (EV) in patients (pts) with advanced or metastatic urothelial carcinoma (UC) with histological variants: EV-VISIBLE trial
2025 · C. Vacheret, F. Moinard-Butot, et al. · European Urology Open Science
Outcome of Metastatic Biliary Tract Cancer Harbouring IDH1 or FGFR2 Alterations: A Retrospective Observational Real-World Study from a French Cohort
2025 · Jean-Baptiste Barbe-Richaud, Fabien Moinard-Butot, et al. · Journal of Clinical Medicine
PDF
1722P Prognostic value of initial radiological depth of response in metastatic gastrointestinal neuroendocrine carcinoma (GI-NEC): The NECTAR study
2025 · J-B. Barbe-Richaud, F. Moinard-Butot, et al. · Annals of Oncology
Retrospective Multicentre Real-Life Study Evaluating the Efficacy of Atezolizumab Combined with Bevacizumab for the Treatment of Metastatic Hepatocellular Carcinoma: HIREAL Study
2025 · Jean-Baptiste Barbe-Richaud, Fabien Moinard-Butot, et al. · Journal of Hepatocellular Carcinoma
PDF
Treatment sequence (TS) and overall survival (OS) in patients with metastatic urothelial cancer (mUC): An observational, multicenter, real-life STATES-Bladder study.
2025 · Fabien Moinard-Butot, Jean-Baptiste Barbe-Richaud, et al. · Journal of Clinical Oncology
PDF
1368P Correlation between depth of response at 6 months and survival in patients (pts) with metastatic non-small cell lung carcinoma (mNSCLC): SPORE trial
2024 · F. Moinard-Butot, J-B. Barbe-Richaud, et al. · Annals of Oncology
PDF
Works count: 17
Citation count: 29
H-index: 2
I10-index: 1
Year
Topic
Type